Physiogenex and Cardiomedex to present a new diabetic NASH HFpEF

Physiogenex and Cardiomedex to present a new diabetic NASH HFpEF hamster model at the Keystone conference

Rana Assaly على LinkedIn: #hfpef #diastolic_dysfunction

Heart Failure With Preserved Ejection Fraction and Diabetes: JACC

Frontiers Heart Failure Syndrome With Preserved Ejection

François Briand en LinkedIn: #nash #fibrosis #obesity

News - Physiogenex

François Briand en LinkedIn: #ksns #nash #obesity #drugdevelopment

Cardiomedex on LinkedIn: #aha23

Physiogenex and Cardiomedex to present a new diabetic NASH HFpEF

Elafibranor improves diet-induced nonalcoholic steatohepatitis

Elafibranor improves diet-induced nonalcoholic steatohepatitis

Physiogenex on LinkedIn: Physiogenex is at ILC-EASL 2022 in London